Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HEXA | P06865 | 1/20 | 0.36 |
| ▸ | HEXB | P07686 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974022 | 0.85 | CNR1 (0.34) | — | |
| SCHEMBL11877248 | 0.82 | TLR8 (0.34) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL1592694 | 0.82 | ELANE (0.34) | TSHRGAAHPGD | |
| SCHEMBL7458208 | 0.81 | HEXA (0.34) | HEXAHEXBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL216731 | 0.81 | — | — | |
| SCHEMBL456469 | 0.81 | CYP2D6 (0.40) | NPC1RAB9ASMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL6048330 | 0.80 | POLB (0.31) | — | |
| SCHEMBL29228990 | 0.79 | TSHR (0.33) | TSHRACHE | |
| SCHEMBL15636515 | 0.79 | DPP4 (0.40) | NPC1RAB9ASMN1; SMN2TSHRHTR7 | |
| SCHEMBL1774729 | 0.78 | DPP4 (0.36) | RAB9ASMN1; SMN2HTR7ALDH1A1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012007007-A1 | INHIBITORS OF HDME | EPITHERAPEUTICS APS (DK) | 2012-01-19 | — | — | WO | claimed |
| US-11720020-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210063879-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| WO-2012007007-A1 | INHIBITORS OF HDME | EPITHERAPEUTICS APS (DK) | 2012-01-19 | — | — | WO | disclosed |
| US-6498182-B2 | BENZO(G)INDOLE -2,5(3H)-DIONE AND -2-ONE DERIVATIVE ANTIDIABETIC AGENTS | BIOVITRUM AB (SE) | 2002-12-24 | — | — | US | disclosed |
| US-20020061921-A1 | Novel compounds | BIOVITRUM AB (SE) | 2002-05-23 | — | — | US | disclosed |
| WO-2002026707-A1 | NOVEL COMPOUNDS | BIOVITRUM AB (SE) | 2002-04-04 | — | — | WO | disclosed |
| WO-1993024468-A1 | PYRIMIDINYL- AND TRIAZINYL- SALICYL- AND PICOLYLAMIDES AND THE USE, AS HERBICIDES, AND PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1993-12-09 | — | — | WO | disclosed |
| US-4381360-A | 1,3-Dicarbonyl compounds and polyvinyl halide resin compositions containing the same | PHOENIX CHEMICAL CORPORATION (US) | 1983-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061921-A1 | Novel compounds | GPR119, IAPP, GLP1R | HEXA 3005/4885HEXB 2253/4885NPC1 769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.